Dr. Edward Garon’s research focuses on developing novel therapies for cancers of the chest (most frequently lung cancer). In his laboratory work, he focuses on determining molecular subtypes of these common cancers. He then evaluates the effects of novel therapeutics against these different subtypes.
In addition to laboratory research, Garon is the principal investigator on a wide range of clinical trials. The ultimate goal of his work is to determine subgroups of lung cancer patients most likely to respond to certain therapies and then translate those observations into rational clinical trials.